Alnylam Pharmaceuticals, Inc. (ALNY)
303.00
+1.89
(+0.63%)
USD |
NASDAQ |
May 06, 16:00
303.99
+0.99
(+0.33%)
Pre-Market: 08:25
Alnylam Pharmaceuticals Free Cash Flow : 641.34M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 10.37B |
| Pfizer Inc. | 9.484B |
| Aldeyra Therapeutics, Inc. | -33.35M |
| Ionis Pharmaceuticals, Inc. | -977.73M |
| Glaukos Corp. | -35.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 70.50M |
| Cash from Investing (Quarterly) | -25.54M |
| Cash from Financing (Quarterly) | 15.71M |
| Free Cash Flow Per Share (Quarterly) | 0.3521 |
| Free Cash Flow to Equity (Quarterly) | 47.24M |
| Free Cash Flow to Firm (Quarterly) | 113.06M |
| Free Cash Flow Yield | 1.56% |